Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $319.0M |
| Sales growthchange from the year before | -37.5% |
| Gross marginshare of sales left after the direct cost of what it sells | 11.9% |
| Operating marginshare of sales left after running the business | -77.0% |
| Net marginshare of sales kept as profit | -90.5% |
| Free-cash-flow marginspare cash generated per $100 of sales | -141.3% |
| Return on equityprofit vs. shareholders' accounting value | n/m |
| Debt / equitydebt vs. shareholders' accounting value | n/m |
| Change in share countnegative = the company is buying back its shares | +24.3% |
1 insider sold $655K (all under pre-arranged plans) on the open market.
| Duchene Todd MSee remarks | Sold (plan)Aug 3 | 10,000 shat $22.23 · $222K |
| Duchene Todd MSee remarks | Sold (plan)Jul 27 | 10,000 shat $20.95 · $209K |
| Duchene Todd MSee remarks | Sold (plan)Jul 20 | 10,000 shat $22.30 · $223K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy